Michael Astrue
Director/Board Member at The National Alliance For Hispanic Health
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Donald Liebentritt | M | 73 |
The National Alliance For Hispanic Health
The National Alliance For Hispanic Health Medical/Nursing ServicesHealth Services The National Alliance For Hispanic Health provides mental health services. The company was founded in 1973 and is headquartered in Washington, DC. | - |
John Cuellar | M | - |
The National Alliance For Hispanic Health
The National Alliance For Hispanic Health Medical/Nursing ServicesHealth Services The National Alliance For Hispanic Health provides mental health services. The company was founded in 1973 and is headquartered in Washington, DC. | - |
Sheila Raviv | F | - |
The National Alliance For Hispanic Health
The National Alliance For Hispanic Health Medical/Nursing ServicesHealth Services The National Alliance For Hispanic Health provides mental health services. The company was founded in 1973 and is headquartered in Washington, DC. | - |
Lourdes Baezconde-Garbanati | M | - |
The National Alliance For Hispanic Health
The National Alliance For Hispanic Health Medical/Nursing ServicesHealth Services The National Alliance For Hispanic Health provides mental health services. The company was founded in 1973 and is headquartered in Washington, DC. | - |
Kevin Adams | M | - |
The National Alliance For Hispanic Health
The National Alliance For Hispanic Health Medical/Nursing ServicesHealth Services The National Alliance For Hispanic Health provides mental health services. The company was founded in 1973 and is headquartered in Washington, DC. | - |
Jane Delgado | M | 71 |
The National Alliance For Hispanic Health
The National Alliance For Hispanic Health Medical/Nursing ServicesHealth Services The National Alliance For Hispanic Health provides mental health services. The company was founded in 1973 and is headquartered in Washington, DC. | 39 years |
Emad Rizk | M | 60 |
The National Alliance For Hispanic Health
The National Alliance For Hispanic Health Medical/Nursing ServicesHealth Services The National Alliance For Hispanic Health provides mental health services. The company was founded in 1973 and is headquartered in Washington, DC. | - |
Martin Castro | M | - |
The National Alliance For Hispanic Health
The National Alliance For Hispanic Health Medical/Nursing ServicesHealth Services The National Alliance For Hispanic Health provides mental health services. The company was founded in 1973 and is headquartered in Washington, DC. | - |
Marcela Manjarrez-Hawn | F | 56 |
The National Alliance For Hispanic Health
The National Alliance For Hispanic Health Medical/Nursing ServicesHealth Services The National Alliance For Hispanic Health provides mental health services. The company was founded in 1973 and is headquartered in Washington, DC. | - |
Gail Wilensky | M | 80 |
The National Alliance For Hispanic Health
The National Alliance For Hispanic Health Medical/Nursing ServicesHealth Services The National Alliance For Hispanic Health provides mental health services. The company was founded in 1973 and is headquartered in Washington, DC. | - |
Amanda Spivey | F | - |
The National Alliance For Hispanic Health
The National Alliance For Hispanic Health Medical/Nursing ServicesHealth Services The National Alliance For Hispanic Health provides mental health services. The company was founded in 1973 and is headquartered in Washington, DC. | - |
Mark McClellan | M | 60 |
The National Alliance For Hispanic Health
The National Alliance For Hispanic Health Medical/Nursing ServicesHealth Services The National Alliance For Hispanic Health provides mental health services. The company was founded in 1973 and is headquartered in Washington, DC. | - |
Drew Altman | M | - |
The National Alliance For Hispanic Health
The National Alliance For Hispanic Health Medical/Nursing ServicesHealth Services The National Alliance For Hispanic Health provides mental health services. The company was founded in 1973 and is headquartered in Washington, DC. | - |
Marcela Gaitán | F | - |
The National Alliance For Hispanic Health
The National Alliance For Hispanic Health Medical/Nursing ServicesHealth Services The National Alliance For Hispanic Health provides mental health services. The company was founded in 1973 and is headquartered in Washington, DC. | - |
Edgar Rico | M | - |
The National Alliance For Hispanic Health
The National Alliance For Hispanic Health Medical/Nursing ServicesHealth Services The National Alliance For Hispanic Health provides mental health services. The company was founded in 1973 and is headquartered in Washington, DC. | - |
Rodrigo Martinez | M | - |
The National Alliance For Hispanic Health
The National Alliance For Hispanic Health Medical/Nursing ServicesHealth Services The National Alliance For Hispanic Health provides mental health services. The company was founded in 1973 and is headquartered in Washington, DC. | - |
Monique Manso | F | - |
The National Alliance For Hispanic Health
The National Alliance For Hispanic Health Medical/Nursing ServicesHealth Services The National Alliance For Hispanic Health provides mental health services. The company was founded in 1973 and is headquartered in Washington, DC. | - |
Javier García Cogorro | M | - |
The National Alliance For Hispanic Health
The National Alliance For Hispanic Health Medical/Nursing ServicesHealth Services The National Alliance For Hispanic Health provides mental health services. The company was founded in 1973 and is headquartered in Washington, DC. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Timothy Morris | M | 62 | 9 years | |
Christopher McNulty | M | 47 | 5 years | |
Francis Reynolds | M | 61 | 8 years | |
Robert Wilson | M | 83 | 1 years | |
David Norton | M | 72 | 7 years | |
Peter Y. Tam | M | 60 | 20 years | |
Mark B. Logan | M | 84 | 15 years | |
Mark D. Perrin | M | 67 | 3 years | |
Alexander Denner | M | 54 | 2 years | |
Linda M. Dairiki Shortliffe | M | 75 | 14 years | |
Leland F. Wilson | M | 80 | 22 years | |
Charles Casamento | M | 78 | 5 years | |
Sam Colin | M | 59 | 2 years | |
Seth Fischer | M | 68 | 4 years | |
Paul M. Finigan | M | 69 |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | 3 years |
Johannes J. P. Kastelein | M | 70 | 2 years | |
Anthony Zook | M | 63 | - | |
Tracy Guo | F | - | - | |
J. Carroll | M | 74 | 1 years | |
Patrick Zenner | M | 77 |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | 1 years |
Ernest Mario | M | 85 | 1 years | |
Ken Bate | M | 73 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 6 years |
Jean-Luc Bélingard | M | 74 |
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | 1 years |
Mona L. Haynes | F | 66 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 5 years |
Cynthia Telles | M | 71 |
The National Alliance For Hispanic Health
The National Alliance For Hispanic Health Medical/Nursing ServicesHealth Services The National Alliance For Hispanic Health provides mental health services. The company was founded in 1973 and is headquartered in Washington, DC. | - |
Jeff Krstich | M | 74 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 6 years |
Darren Braccia | M | - |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 2 years |
Sandra E. Wells | M | - | - | |
Torsten Rüdiger Goesch | M | 65 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 2 years |
Mark Stejbach | M | 61 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 3 years |
Robert A. Hamm | M | 72 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 9 years |
Michael Miller | M | 67 | 4 years | |
Decebal Bora | M | - |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | - |
Steven F. McAllister | M | 65 | 3 years | |
Ajay Bansal | M | 62 |
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | 2 years |
Victor E. Kotelianski | M | - |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | - |
Timothy M. Kish | M | 72 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 7 years |
Gregory Perry | M | 63 | - | |
Elan Ezickson | M | 60 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 2 years |
Lee B. Perry | M | 73 | 8 years | |
Louis Vaickus | M | - | - | |
Michael R. Slater | M | 77 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 10 years |
Morris Z. Rosenberg | M | 64 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 8 years |
Christopher Rivera | M | 63 |
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | 1 years |
Thomas Wiggans | M | 72 |
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | 1 years |
Christophe Jean | M | 67 |
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | 2 years |
Joseph M. Davie | M | 84 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 7 years |
Barbara Troupin | M | 56 | 8 years | |
Sean Moran | M | 66 | 3 years | |
John Alam | M | 62 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 6 years |
Frederick B. Oleson | M | - |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 5 years |
David D. Pendergast | M | 76 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 5 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 70 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Michael Astrue
- Personal Network